Evidence map›Paper›PMID 40352814›Full record

ReviewGreen chemistry : an international journal and green chemistry resource : GC2025

Natural deep eutectic solvents (NaDES): green solvents for pharmaceutical applications and beyond.

Emma Chevé-Kools, Young Hae Choi, Catherine Roullier, Gwenaël Ruprich-Robert, Raphaël Grougnet, Florence Chapeland-Leclerc, Frank Hollmann

Abstract readReview
In one paragraph

Review in Green chemistry : an international journal and green chemistry resource : GC, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Valorization of Garlic (Molecules (Basel, Switzerland) · 2026
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Emma Chevé-KoolsCibles Thérapeutiques et Conception de Médicaments (CiTCoM, UMR 8038 CNRS), Faculté de Pharmacie de Paris, Université Paris Cité Paris France emma.cheve@free.fr florence.leclerc@u-paris.fr.ORCID https://orcid.org/0009-0000-0057-5013
Young Hae ChoiNatural Products Laboratory, Institute of Biology, Leiden University Leiden The Netherlands.ORCID https://orcid.org/0000-0003-1484-1700
Catherine RoullierInstitut des Substances et Organismes de la Mer (ISOMER, UR 2160), Faculté de Pharmacie de Nantes, Nantes Université France.
Gwenaël Ruprich-RobertCibles Thérapeutiques et Conception de Médicaments (CiTCoM, UMR 8038 CNRS), Faculté de Pharmacie de Paris, Université Paris Cité Paris France emma.cheve@free.fr florence.leclerc@u-paris.fr.ORCID https://orcid.org/0000-0003-3679-428X
Raphaël GrougnetCibles Thérapeutiques et Conception de Médicaments (CiTCoM, UMR 8038 CNRS), Faculté de Pharmacie de Paris, Université Paris Cité Paris France emma.cheve@free.fr florence.leclerc@u-paris.fr.ORCID https://orcid.org/0000-0003-1657-2997
Florence Chapeland-LeclercCibles Thérapeutiques et Conception de Médicaments (CiTCoM, UMR 8038 CNRS), Faculté de Pharmacie de Paris, Université Paris Cité Paris France emma.cheve@free.fr florence.leclerc@u-paris.fr.ORCID https://orcid.org/0000-0002-6672-5501
Frank HollmannDepartment of Biotechnology, Delft University of Technology Delft The Netherlands.ORCID https://orcid.org/0000-0003-4821-756X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Composed of various biosourced metabolites, NaDES offer significant economic, health, and environmental benefits. Their remarkable ability to interact with target compounds through non-covalent bonds enhances their versatility. As solvents, excipients, cofactors, catalysts, solubilisation promoters, stabilisers, and absorption agents, NaDES provide distinct advantages over conventional substances and can even act as active compounds themselves. Furthermore, their role in advancing innovative synthesis and formulation strategies, particularly in nanotechnology and biotechnology, is driving research in these areas. This review is the first to explore all the potential applications of NaDES in the pharmaceutical industry, while taking a comprehensive look at the theory behind them. It gives a precise definition of NaDES and describes their composition, characteristics, molecular interactions, preparation, stability and recovery. It presents detailed applications in pharmaceutical synthesis, extraction and formulation, and discusses roles as active compounds or tools for innovation. Using green metrics, the efficiency of routes including NaDES is compared to that of conventional processes. Lastly, this review addresses often overlooked points such as toxicity and process limitations.

Identifiers

PMID40352814
PMCPMC12062791

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.